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Background: It was reported that 64% of tic disorder patients used complementary and alternative medicine. This
review aims to evaluate the efficacy of herbal medicines in treating tic disorders.
Methods: We searched eight databases including MEDLINE and CINAHL from their respective inceptions up to
September 2013. The search terms were related to the concept of “herbal medicine” AND “tic disorder OR
Tourette’s syndrome”. We included randomised controlled trials (RCTs) of any type of herbal medicines. We assessed
the methodological quality of the trials according to the Cochrane risk of bias criteria.
Results: Sixty one studies were identified, and four RCTs met the inclusion criteria. Two types of herbal medicines,
Qufeng Zhidong Recipe (QZR) decoction and Ningdong (ND) granules, were used in the included RCTs. All four
RCTs had a high risk of bias. Two RCTs tested the effects of QZR on the Yale Global Tic Severity Scale (YGTSS) score
and response rate compared with conventional medicine. The meta-analysis showed significant effects of QZR on
the YGTSS score with high statistical heterogeneity (n = 142; weighted mean difference: −18.34; 95% confidence
interval (CI): −23.07 to −13.60; I2 = 97%) and the response rate (n = 142; risk ratio: 1.69; 95% CI: 1.39 to 2.06; I2 = 0%).
One RCT compared ND granules with placebo and showed significant effects on the YGTSS score and response
rate. The other RCT show significant effects of ND granules plus conventional medicine on the response rate
compared with conventional medicine only.
Conclusion: This systematic review provided first piece of limited meta-analytic evidence for the effectiveness
of herbal medicines in improving the symptoms of tic disorders.Background
Tic disorders, which are characterised by sudden, repeti-
tive, nonrhythmic motor movement or vocalisation, are
observed in approximately 6–20% of children in world-
wide [1]. The tic disorder spectrum ranges from mild to
more severe, and the disorders are classified by duration
and severity into transient tic, chronic tic, or Tourette’s
syndrome [2-4]. Although functional impairment is rela-
tively rare, tic disorders can affect academic achieve-
ment, sleep quality, and emotional status (including
anxiety or depression), and in severe cases, they can
cause social withdrawal [5].
The exact cause of tic disorders is unknown. Until the
1960s, psychogenic factors were regarded as the primary* Correspondence: drmslee@gmail.com
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unless otherwise stated.cause [6]. Recently, the domain of tic disorders has
moved to the border between neurology and psychology
[6]. Neuroimaging evidence suggested that an imbalance
in the dopaminergic system increased the expression of
presynaptic dopamine transporters and causes excessive
dopaminergic innervation [7].
Antipsychotic drugs that function as dopamine recep-
tor antagonists are used to treat tic disorders [1,6], and
the efficacy of antipsychotic drugs, such as haloperidol
and pimozide, has been demonstrated in clinical trials
[4,7]. However, many clinicians are reluctant to use these
drugs because of the potential adverse effects [6]. Tic
disorder patients are increasingly using complementary
and alternative medicine (CAM), and one study reported
that 64% of tic disorder patients received CAM [8]. Ani-
mal studies on the effect of herbal medicines in treating
tic disorders [9,10].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of the clinical studies on the beneficial and adverse effects
of herbal medicines on tic disorders. This systematic re-
view of randomised controlled trials (RCTs) aims to evalu-
ate the efficacy of herbal medicines in treating tic
disorders.
Methods
Search methods used to identify studies
The following databases were searched from their re-
spective inceptions up to September 2013: MEDLINE;
Cumulative Index to Nursing and Allied Health Litera-
ture (CINAHL); SciVerse Scopus (SCOPUS); EBSCO
Academic Search; Cochrane Central Register of Con-
trolled Trials (CENTRAL); a Chinese database (China
Network Knowledge Infrastructure [CNKI]); and two
Korean databases (Oriental Medicine Advanced Search-
ing Integrated System [OASIS] and Korean Studies In-
formation Service System [KISS]). The search strategy is
listed in Table 1. No language restrictions were imposed.
Dissertations and abstracts were included.
Selection criteria regarding the types of studies
RCTs and quasi-RCTs of the use of herbal medicines for
treating tic disorders and Tourette’s syndrome wereTable 1 Medline (PubMed) search strategy (* used as the
wildcard character Truncating search terms for searching
for all terms that begin with a word)
#1 tic disorder [mh]
#2 Tourette’s syndrome [mh]
#3 1 or 2
#4 Medicine, African Traditional [mh]
#5 Medicine, Arabic [mh]
#6 Medicine, Ayurvedic [mh]
#7 Medicine, Kampo [mh]
#8 Medicine, Korean Traditional [mh]
#9 Medicine, Tibetan Traditional [mh]
#10 Medicine, Mongolian Traditional [mh]
#11 Herbal Medicine [mh]
#12 Phytotherapy [mh]
#13 Drugs, Chinese Herbal [mh]
#14 Plants, Medicinal [mh]





#20 Any of 4–19
#21 3 and 20included. We included both parallel-group and crossover
study designs.
Participants
We focused on the patients with clinical diagnoses of tic
disorders (persistent or provisional) or Tourette’s syn-
drome who met the Diagnostic and Statistical Manual
of Mental Disorders (DSM) III, IV, or V criteria. Studies
with both children and adults were included.
Interventions
Studies that used herbal medicines or combination ther-
apy with conventional medicine versus placebo or other
medications were included. Combinations of herbal
medicines and non-medicinal therapy, such as acupunc-
ture, and comparisons between different types of herbal
medicines were excluded. We defined herbal medicines
as product decoctions, concoctions, capsules, tablets,
and powders that originated from botanical sources,
such as whole plants or their adjuncts [11]. However,
single-chemical extracts or synthetic plant-based drugs
were excluded. Only interventions that used medications
taken internally were included, and other CAM treat-
ments were excluded. There were no restrictions on fre-
quency, dose, or duration.
Outcome measures
The primary outcomes analysed for the review were tic se-
verity, intensity, complexity, and interference. These out-
comes were measured by the Yale Global Tic Severity
Scale (YGTSS), Tic Symptom Score Scale, Tourette’s
Syndrome Global Scale, and a self-rating scale (Tourette’s
Syndrome Symptom List). The secondary outcomes ana-
lysed for the review were adverse events, as measured by
the Treatment Emergent Symptom Scale, electroencepha-
lograms, laboratory tests (erythrocyte sedimentation rate ,
kidney and liver function tests), and electrocardiogram ab-
normalities or changes.
Data extraction
All articles were read by two independent reviewers
(YHK, CGS) who also extracted data according to the
following predefined criteria: disease severity; interven-
tions for treatment and control groups; trial duration;
outcome measurements; and recipes of herbal medi-
cines. Any disagreement between the two reviewers
(YHK, CGS) was solved by discussion.
Assessment of risk of bias in the included studies
Two reviewers (YHK, HYL) independently assessed the
risk of bias in the included studies according to the cri-
teria set forth in the Cochrane Handbook version 5.1.0,
which include random sequence generation, allocation
concealment, blinding of participants and personnel,
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data, selective reporting, and other sources of bias [12].
Any differences in opinion were resolved through dis-
cussion or consultation with the third reviewer (MSL).
Data synthesis
The values (end of treatment) of the outcome measures
after treatment were used to assess differences between
the herbal medicine groups and control groups. We did
not include any follow-up treatment values. Weighted
mean differences (WMDs) were used when studies mea-
sured the outcomes on the same scale, and standard
mean differences (SMDs) were used when studies mea-
sured the outcomes on different scales using random-
effects model. These values were obtained using Review
Manager 5.1 (Copenhagen: The Nordic Cochrane Centre,
The Cochrane Collaboration, 2011). Risk ratios (RRs) and
95% confidence intervals (CIs) were assessed for the binary
data. The χ2, τ2, and Higgins I2 were used to assess hetero-
geneity. P < 0.05 was considered statistically significant.Figure 1 Flow chart of the publication selection process. RCT: randomResults
Characteristics of the studies
Sixty-one papers were extracted in the initial screening
of the eight databases. There were five RCT-based pa-
pers. One RCT [13] was subsequently excluded, as the
assessment had no valid outcome. Four papers were ul-
timately selected for the review process and data analysis
(Figure 1 and Table 2) [14-17]. All four studies were de-
signed with parallel groups (only two arms), and the
diagnosis was made using the DSM-IV criteria. One trial
[16] was a randomised double-blind study, and the
other three trials [14,15,17] were randomised open-
label studies.
In total, 296 patients participated in the four studies,
and all patients were younger than 18 years. The mean
sample size was 74 (range: 61–90), and the mean study
duration was 20 weeks (range: 8–24 weeks). The patients
in two trials [14,15] were diagnosed with tic disorders,
while the other two studies [16,17] examined Tourette’s
syndrome.ised clinical trial.
Table 2 Summary of RCTs using herbal medicines for tic disorders
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(B) Haloperidol and
trihexyphenidyl
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200 ml daily for
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(B) Haloperidol and
trihexyphenidyl
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Li et al. (2009) [17] 90 (A) ND (granules,
3–9 g daily for
24 wks, n = 60),
plus (B)
(B) Haloperidol
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(1) YGTSS
Score
(1) MD −4.35 [−7.34, –1.36],
P< 0.01
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evaluate two herbal decoctions (Table 3). Two studies
compared Qufeng Zhidong Recipe (QZR) decoction with
haloperidol [14,15]. In the other studies, Ningdong (ND)
granules or ND granules plus haloperidol were com-
pared with placebo or haloperidol alone [16,17].Risk of bias
As shown in Table 4, the randomisation methods were not
described in two studies [15,16], while the other two trials
referred to a random number table [14,17]. No details were
provided for the method of allocation concealment in any
of the studies. Only one trial was a double-blind study [16],
and the others were open-label studies. Reporting of drop-
out cases was provided for three trials, but the detailed rea-
sons were not shown [14-16], while the last trial did not
report dropout cases [17]. Selective reporting bias couldnot be evaluated because of the unclear descriptions of the
preregistered protocols.QZR versus conventional medicine
The two QZR trials included a single-site trial [15] and a
multicentre trial [14] examining QZR versus the com-
bination of haloperidol and trihexyphenidyl in tic disor-
ders. In the single-site trial, the YGTSS score were
decreased in both groups, but the QZR-treated group
showed a significant improvement compared with the
control group after 24 weeks [15]. The multicentre study
found a significant improvement in the YGTSS score of
the treatment group compared with the control group
after administering the drugs for 24 weeks [14]. The
meta-analysis showed significant superior effects of QZR
on improvement of the YGTSS score compared with con-
ventional drug treatment (haloperidol plus trihexyphenidyl)
Table 3 Preparation of herbal medicines for tic disorders
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0.00001; Figure 2A) with high heterogeneity (τ2 = 11.26;
χ2 = 28.62; P < 0.00001; I2 = 97%). QZR showed a sig-
nificant improvement compared with conventional
medicine in response rate (n = 142; RR: 1.69; 95% CI:
1.39 to 2.06; heterogeneity: τ2 = 0; χ2 = 0.05; P= 0.82; I2 = 0%;
Figure 2B).
ND granules versus placebo
One RCT evaluated the effect of ND granules in treating
Tourette’s syndrome compared with placebo [16]. Com-
pared with the placebo group, administration of ND







Wu et al. (2009) [14] L U
Wu et al. (2010) [15] U U
Zhao et al. (2010) [16] L U
Li et al. (2009) [17] U U
L low risk of bias; U unclear risk of bias; H high risk of bias.score (n = 64; MD: −6.52; 95% CI: −9.80 to −3.24;
P < 0.0001; Figure 2C) and the response rate (n = 64; RR:
4.30; 95% CI: 1.68 to 11.0; Figure 2D).
ND granules plus haloperidol versus haloperidol only
One RCT tested ND granules plus haloperidol for treat-
ing Tourette’s syndrome compared with haloperidol only
[17]. After 24 weeks of treatment, the group that re-
ceived ND granules plus haloperidol showed significant
decreases in the total YGTSS score (n = 90; MD: –4.35;
95% CI: −7.34 to −1.36; Figure 2E) and the response rate
(n = 90; RR: 1.30; 95% CI: 1.04 to 1.62; Figure 2F) com-
pared with the haloperidol only group.
Adverse effects of QZR and ND granules
In the two QZR trials, no significant adverse events were
observed, except for slight loss of appetite, whereas the
participants in the haloperidol group experienced weight
gain, hypopraxia, and drowsiness despite using trihexy-
phenidyl [14,15]. In the trial of ND granules plus halo-
peridol compared with haloperidol only, both groups
showed lassitude, drowsiness, and poor appetite. The ad-
verse reaction rates were 13.3% in the ND granules plus
haloperidol group and 36.7% in the haloperidol only
group [17]. In the study of ND granules versus placebo,
6.1% of the participants reported loss of appetite and 3%
experienced constipation in the ND granules group
compared with no adverse reactions in the placebo
group [16].
Discussion
To our knowledge, this is the first systematic review of
the effects of herbal medicines for tic disorders. The re-
sults suggested that QZR and ND granules were effective
in treating tic disorders or Tourette’s syndrome. How-
ever, the evidence suggesting that QZR and ND granules
represented an effective modality for treating tic disor-
ders or Tourette’s syndrome was limited by small num-
ber of trials and the high risk of bias in primary trials.
Only two of the included trials reported randomisation
methods, and only one used a placebo control. Conceal-
ment of treatment allocation was not reported in any of
the studies. Trials with inadequate blinding and inadequate







H U U U
H U U U
H U U U
L U U U
Figure 2 Forest plot of the effects of herbal medicines on the Yale Global Tic Severity Scale (YGTSS) score and response rate. HM:
herbal medicine.
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study results.
In the four trials, the method for assessing the effects
of QZR and ND granules was identical in using the
YGTSS score. However, the YGTSS scores in the twoTourette’s syndrome studies were much lower than
those in the two QZR studies. These observations indi-
cated that Wu’s group selected severe tic disorder cases,
although Tourette’s syndrome is generally more severe
than tic disorders. Two trials seemed to be duplicate
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come measures, except for the sample size, and the same
first author, and were performed within similar periods of
time. We contacted the authors to clarify these points,
and the answer was that one paper described results from
a multicentre study and the other reported results from a
single-centre study. The authors might have included dif-
ferent numbers of sub-centres in the two articles. We also
requested clarification for the other two studies with re-
gard to whether they might possibly describe four-armed
trials, but the authors did not answer. Even if this were
true, it would not overrule our conclusion.
QZR and ND granules appeared to have potential for
treating patients with tic disorders. There was also other
evidence of their pharmaceutical effects and underlying
mechanisms. QZR improved tic behaviour in mouse and
rat models [10,19] while ND granules were effective for
treating attention-deficit/hyperactivity disorder in an RCT
and inhibited stereotypic behaviour in a Tourette’s syn-
drome rat model by modulating dopamine production and
expression of the dopamine D2 receptor gene [9,20,21].
Gastrodia elata Blume is the main herb in both QZR and
ND granules [14-17]. It had neuroprotective effects on hu-
man dopaminergic SH-SY5Y cells and an antidepressant-
like effect via regulation of both the serotonergic and
dopaminergic systems in a rat model [22,23].
Although our search strategy might locate all relevant
data, there might be some unidentified studies and un-
published studies with negative results. Unpublished
RCTs with negative results could provide different out-
come with this review [24].
Conclusions
This systematic review provided first piece of limited
meta-analytic evidence for the effectiveness of herbal
medicines in improving the symptoms of tic disorders.
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